On June 13, 2024 CVS Health announced a plan to split the company into two publicly traded entities – CVS Pharmacy and Aetna – with the separation slated for completion by December 31, 2025. The move, disclosed in a filing with the SEC, is expected to create a $120 billion combined market value, generate $1.5 billion in annual cost synergies, and caused CVS shares to jump 4.2% in after‑hours trading.
The breakup challenges the long‑standing integrated‑care model that has dominated U.S. health services, potentially accelerating consolidation among pure‑play insurers like UnitedHealth and pharmacy chains such as Walgreens. It also signals to regulators and investors that large, vertically integrated health firms may need to disentangle to unlock shareholder value and reduce antitrust scrutiny.